TipRanks
Go Ultimate55% OFF

Robert Gould Insider Profile

4 Followers

Robert Gould, Director at Fulcrum Therapeutics, holds 454.86K shares in Fulcrum Therapeutics (Ticker: FULC), holds 0.00 shares in Epizyme (Ticker: EPZM), holds ― shares in Turnstone Biologics Corp. (Ticker: TSBX).

Robert Gould's Trading History

FULC
Fulcrum Therapeutics
Feb 04, 2026DirectorUninformative Sell160.80K$1.69M
EPZM
Epizyme
Dec 30, 2015―Uninformative Sell578.06K$0.00
TSBX
Turnstone Biologics Corp.
――――

You May Also Like

Robert Gould insider profile FAQ

What stocks does Robert Gould hold?
Robert Gould holds: FULC, EPZM, TSBX stocks.
What was Robert Gould’s latest transaction?
Robert Gould’s latest transaction was an Uninformative Sell of $160.80K.
What is Robert Gould's role in Fulcrum Therapeutics?
Robert Gould's role in Fulcrum Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.